The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The Correction Factors Do Help in Improving the Prediction of Human Clearance from Animal Data
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The MLBF method is particularly applicable to drugs that are not readily metabolized and/or renally excreted when administered intravenously.
“In addition, the MLBF method is particularly applicable to drugs that are not readily metabolized and/or renally excreted when administered intravenously [101].”
From Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling (2019) · cites this paper as [101]
Citations
Cites
Interspecies Scaling: Predicting Clearance of Drugs in Humans. Three Different Approaches
Mahmood, I., & Balian, J. D. (1996) · Xenobiotica · doi:10.3109/00498259609052491 · Cited by 257
Self-citationLave, T. H., Dupin, S., Schmitt, C., Chou, R. C., Jaeck, D., & Coassolo, P. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960440h · Cited by 184
Nagilla, R., & Ward, K. W. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20169 · Cited by 96
Flagged first, then by citations
Research works printed but not linked: 43
- Wajima, 2002, Prediction of human clearance from animal data and molecular structural parameters using multivariate regression analysis, J Pharm Sci, 91, 2489, 10.1002/jps.10242 · DOI
- Boxenbaum, 1984, Scaling of antipyrine intrinsic clearance of unbound drug on 15 mammalian species, Eur J Drug Metab Pharmacokinet, 9, 177, 10.1007/BF03189622 · DOI
- Obach, 1997, The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism, J Pharmacol Exp Ther, 283, 46
- Karalis, 2002, Drug disposition viewed in terms of the fractal volume of distribution, Pharm Res, 19, 696
- Davies, 1993, Physiological parameters in laboratory animals and humans, Pharm Res, 10, 1093, 10.1023/A:1018943613122 · DOI
- Mahmood, 2002, Interspecies scaling of biliary excreted drugs, J Pharm Sci, 91, 1908, 10.1002/jps.10174 · DOI · Paper page
- Duhart, 1993, Pharmacokinetics of cocaine in pregnant and nonpregnant rhesus monkeys, Reprod Toxicol, 7, 429, 10.1016/0890-6238(93)90087-N · DOI
- Clement, 1990, Pharmacokinetics of the acetylcholinesterase oxime reactivator, HI-6, in rhesus monkeys (Macaca mulatta): Effect of atropine, diazepam, and methoxyflurane anesthesia, Biopharm Drug Dispos, 11, 227, 10.1002/bdd.2510110307 · DOI
- de Miranda, 1982, Species differences in the disposition of acyclovir, Am J Med, 73, 31, 10.1016/0002-9343(82)90059-6 · DOI
- Johnson, 1985, Metabolism and disposition of amifloxacin in laboratory animals, Antimicrob Agents Chemother, 27, 774, 10.1128/AAC.27.5.774 · DOI
- El Dareer, 1977, Distribution and metabolism of prednisone in mice, dogs, and monkeys, Cancer Treat Rep, 61, 1279
- El Dareer, 1977, Distribution and metabolism of vincristine in mice, rats, dogs, and monkeys, Cancer Treat Rep, 61, 1269
- Yeung, 1983, Drug–protein conjugates—IV. The effect of acute renal failure on the disposition of [14C]captopril in the rat, Biochem Pharmacol, 32, 2467, 10.1016/0006-2952(83)90003-5 · DOI
- Tse, 1990, Disposition of fluvastatin, an inhibitor of HMG-COA reductase, in mouse, rat, dog, and monkey, Biopharm Drug Dispos, 11, 519, 10.1002/bdd.2510110606 · DOI
- Chang, 1987, Preclinical and clinical pharmacokinetics of pirmenol, Am J Cardiol, 59, 15H, 10.1016/0002-9149(87)90139-1 · DOI
- Sanwald-Ducray, 1997, Prediction of the pharmacokinetic parameters of reduced dolasetron in man using in vitro-in vivo and interspecies allometric scaling, Xenobiotica, 27, 189, 10.1080/004982597240686 · DOI
- Dockens, 2000, Disposition of radiolabeled ifetroban in rats, dogs, monkeys, and humans, Drug Metab Dispos, 28, 973
- Maruhn, 1985, Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey, Arzneimittelforschung, 35, 1781
- Salmon, 1983, Pharmacokinetics and metabolism of moxestrol in animals: Rat, dog and monkey, J Steroid Biochem, 19, 1223, 10.1016/0022-4731(83)90421-1 · DOI
- Salmon, 1983, Pharmacokinetics and metabolism of moxestrol in humans, J Steroid Biochem, 18, 565, 10.1016/0022-4731(83)90132-2 · DOI
- Turner, 1975, Influence of route of administration on metabolism of [14C]nicotine in four species, Xenobiotica, 5, 553, 10.3109/00498257509056125 · DOI
- Runkel, 1972, Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects, J Pharm Sci, 61, 703, 10.1002/jps.2600610507 · DOI
- Boyes, 1970, Oral absorption and disposition kinetics of lidocaine hydrochloride in dogs, J Pharmacol Exp Ther, 174, 1
- Sawada, 1984, Prediction of the disposition of β-lactam antibiotics in humans from pharmacokinetic parameters in animals, J Pharmacokin Biopharm, 12, 241, 10.1007/BF01061720 · DOI
- Eriksson, 1998, Animal pharmacokinetics of inogatran, a low-molecular-weight thrombin inhibitor with potential use as an antithrombotic drug, Biopharm Drug Dispos, 19, 55, 10.1002/(SICI)1099-081X(199801)19:1<55::AID-BDD74>3.0.CO;2-H · DOI
- Cruze, 1995, Interspecies scaling of tebufelone pharmacokinetic data and application to preclinical toxicology, Pharm Res, 12, 895, 10.1023/A:1016273306956 · DOI
- Lave, 1996, Animal pharmacokinetics and interspecies scaling from animals to man of lamifiban, a new platelet aggregation inhibitor, J Pharm Pharmacol, 48, 573, 10.1111/j.2042-7158.1996.tb05976.x · DOI
- Ritschel, 1991, Interspecies scaling of the pharmacokinetic parameters of coumarin among six different mammalian species, Methods Find Exp Clin Pharmacol, 13, 697
- Giachetti, 1998, Pharmacokinetic study in dogs and monkeys after single intravenous and oral administrations of [14C]-ITF-296, Eur J Drug Metab Pharmacokin, 23, 239, 10.1007/BF03189346 · DOI
- Monzani, 1995, Pharmacokinetic profile of ITF 296 in rats and dogs, J Cardiovasc Pharmacol, 269, S67, 10.1097/00005344-199526004-00012 · DOI
- Sardina, 1995, Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers, J Cardiovasc Pharmacol, 269, S72, 10.1097/00005344-199526004-00013 · DOI
- Monzani, 1999, Pharmacokinetics of ITF 296 (Sinitrodil) a novel organic nitrate, in healthy volunteers, Eur J Pharm Sci, 7, 179, 10.1016/S0928-0987(98)00026-8 · DOI
- Cook, 1993, Pharmacokinetics of a novel antiarrhythmic drug, actisomide, Pharm Res, 10, 427, 10.1023/A:1018900725050 · DOI
- Tanaka, 1999, In vivo and in vitro trimethadione oxidation activity of the liver from various animal species including mouse, hamster, rat, rabbit, dog, monkey and human, Hum Exp Toxicol, 18, 12, 10.1191/096032799678839356 · DOI
- Efthymiopoulos, 1991, Animal pharmacokinetics and interspecies scaling of FCE 22101, a penem antibiotic, J Antimicrob Chemother, 4, 517, 10.1093/jac/27.4.517 · DOI
- Jannuzzo, 1989, Pharmacokinetics and tolerance of a new penem antibiotic, FCE 22101, in healthy volunteers after a single intravenous dose, Eur J Clin Pharmacol, 36, 633, 10.1007/BF00637750 · DOI
- Doyle, 1982, Comparative pharmacokinetics of frusemide in female rhesus monkeys, cynomolgus monkeys and baboons, Comp Biochem Physiol C, 71C, 89, 10.1016/0306-4492(82)90015-6 · DOI
- Hirai, 1992, The pharmacokinetics and pharmacodynamics of furosemide in the anaesthetized dog, J Vet Pharmacol Ther, 15, 231, 10.1111/j.1365-2885.1992.tb01011.x · DOI
- Prandota, 1991, Pharmacokinetic, biliary excretion, and metabolic studies of 14C-furosemide in the rat, Xenobiotica, 21, 725, 10.3109/00498259109039512 · DOI
- Teng, 1996, Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys, Antimicrob Agents Chemother, 40, 561, 10.1128/AAC.40.3.561 · DOI
- Vincent, 1997, Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin, J Antimicrob Chemother, 39, 75, 10.1093/jac/39.suppl_2.75 · DOI
- Ivarone, 1999, First time in human for GV196771: Interspecies scaling applied on dose selection, J Clin PharmacoI, 39, 560, 10.1177/00912709922008164 · DOI
- Ward, 2004, A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance, Drug Metab Dispos, 32, 603, 10.1124/dmd.32.6.603 · DOI · Paper page
Cited by
Sorted by citations
Huang, Q., & Riviere, J. E. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.934671 · Cited by 149
Horvath, C. J., & Milton, M. N. (2009) · Toxicologic Pathology · doi:10.1177/0192623309332986 · Cited by 87
Choi, G.-W., Lee, Y.-B., & Cho, H.-Y. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11040168 · Cited by 79
“In their studies, they compared the CL value of antiepileptic drugs using four different allometric equations: a simple AS in Equation (74), the product of CL and MPL in Equation (75), the Boxenbaum’s two-term power function in Equation (77), and the product of CL and BW in Equation (76), a novel equation developed by…”
MethodInfluential
Metadata
- Authors
- Mahmood, I.
- Affiliations
- United States Food and Drug Administration (US)
- Corresponding author
- Mahmood, Iftekhar
- ORCID
- Mahmood, Iftekhar
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 94
- Issue
- 5
- Pages
- 940-945
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2083159335
- Cited by
- 13
- References
- 3
- Citations by year
- 2019: 2 · 2014: 2 · 2012: 1
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- animal-to-human extrapolation, correction factors, pharmacokinetics, interspecies scaling
- MeSH terms
- Algorithms, Animals, Chemistry, Pharmaceutical, Data Interpretation, Statistical, Pharmaceutical Preparations, Humans, Pharmacokinetics, Predictive Value of Tests, Species Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review